Hikma Pharmaceuticals Plc Block listing Interim Review
02 Aprile 2024 - 10:50AM
RNS Regulatory News
RNS Number : 9474I
Hikma Pharmaceuticals Plc
02 April 2024
Hikma Pharmaceuticals
PLC
Block Listing Six Monthly
Return
Date: 2 April 2024
|
Name of applicant:
|
Hikma Pharmaceuticals PLC
|
|
Name of scheme:
|
Hikma Pharmaceuticals PLC 2018
Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC
2014 Executive Incentive Plan ("EIP") (together "the Plans")
|
|
Period of return
|
From: 1 October 2023
|
To:
|
31 March 2024
|
|
Balance of unallotted securities
under scheme(s) from previous return:
|
The Plans: 1,118,710 Ordinary Shares
of 10 pence
|
|
Plus: The amount by which
the block scheme(s) has been increased since the date of the last
return (if any increase has been applied for):
|
The Plans: 0 Ordinary Shares of 10
pence
|
|
Less: Number of
securities issued/allotted
under scheme(s) during period (see LR3.5.7G):
|
2018 MIP: 494,322 Ordinary Shares of
10 pence
EIP: 311,764 Ordinary Shares of 10
pence
|
|
Equals: Balance under
scheme(s) not yet issued/allotted at end of period:
|
The Plans: 312,624 Ordinary Shares
of 10 pence
|
|
Name of contact:
|
Helen Middlemist
|
|
Telephone number of
contact:
|
+44(0)20 7399 2760
|
Hikma Pharmaceuticals PLC (LSE: HIK)
(NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI:
549300BNS685UXH4JI75)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BLRUPUUACUPCURP
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Mar 2025
